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Abstract
Background: Chronic bone cancer pain is thought to be partly due to central sensitization. Although murine models 
of bone cancer pain revealed significant neurochemical changes in the spinal cord, it is not known whether this 
produces functional alterations in spinal sensory synaptic transmission. In this study, we examined excitatory synaptic 
responses evoked in substantia gelatinosa (SG, lamina II) neurons in spinal cord slices of adult mice bearing bone 
cancer, using whole-cell voltage-clamp recording techniques.
Results: Mice at 14 to 21 days after sarcoma implantation into the femur exhibited hyperalgesia to mechanical stimuli 
applied to the skin of the ipsilateral hind paw, as well as showing spontaneous and movement evoked pain-related 
behaviors. SG neurons exhibited spontaneous excitatory postsynaptic currents (EPSCs). The amplitudes of 
spontaneous EPSCs were significantly larger in cancer-bearing than control mice without any changes in passive 
membrane properties of SG neurons. In the presence of TTX, the amplitude of miniature EPSCs in SG neurons was 
increased in cancer-bearing mice and this was observed for cells sampled across a wide range of lumbar segmental 
levels. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor- and N-methyl-D-aspartate 
(NMDA) receptor-mediated EPSCs evoked by focal stimulation were also enhanced in cancer-bearing mice. Dorsal root 
stimulation elicited mono- and/or polysynaptic EPSCs that were caused by the activation of Aδ and/or C afferent fibers 
in SG neurons from both groups of animals. The number of cells receiving monosynaptic inputs from Aδ and C fibers 
was not different between the two groups. However, the amplitude of the monosynaptic C fiber-evoked EPSCs and the 
number of SG neurons receiving polysynaptic inputs from Aδ and C fibers were increased in cancer-bearing mice.
Conclusions: These results show that spinal synaptic transmission mediated through Aδ and C fibers is enhanced in 
the SG across a wide area of lumbar levels following sarcoma implantation in the femur. This widespread spinal 
sensitization may be one of the underlying mechanisms for the development of chronic bone cancer pain.
Background
Pain is one of the most common symptoms of patients
with primary bone sarcomas and those with bone metas-
tases from lung or other solid tumors [1,2]. It is a trouble-
some clinical problem since current treatments are not
fully effective. As the disease progresses, chronic pain
develops and often becomes resistant to conventional
analgesic treatments such as anti-inflammatory drugs
and opioids even at the maximum doses that can be toler-
ated [2,3]. Despite the global efforts designed to treat
both bone cancer and cancer-related pain, nearly 70% of
the patients dying from cancer experience unrelieved
pain which is usually progressive and severe [4].
In recent years, preclinical animal models of bone can-
cer pain have been developed and the mechanisms con-
tributing to bone cancer pain have been studied at
cellular and behavioral levels [5-8]. Implantation of can-
cer cells within the femur or tibia induces ongoing pain-
related behaviors such as licking and flinching of the ipsi-
lateral hind limb following bone destruction [9-12] asso-
ciated with injuries of the primary afferent fibers
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innervating the cancer-bearing bones [12]. In addition to
these spontaneous behavioral changes, previous studies
show that animals bearing bone cancer also exhibit allo-
dynia and/or hyperalgesia in response to natural sensory
stimuli applied to the non-cancerous skin [9,12,13]. In
addition to sensitization of afferent fibers in animals
bearing bone cancer [5], the excitability (firing rates) of
spinal dorsal horn neurons in response to cutaneous sen-
sory stimuli is reported to be increased [8,14] along with
an enlargement of their receptive field sizes [8]. These
functional changes in responsiveness of spinal dorsal
horn neurons may be induced not only by peripheral sen-
sitization of afferent fibers innervating the cancerous
bone, but also by processes of spinal sensitization, such as
plastic changes in spinal noxious circuitry or in synaptic
transmission as has been reported in other animal mod-
els of peripheral nerve injuries and inflammation [15].
Extensive neurochemical reorganization and gliosis in the
spinal dorsal horn of animals bearing bone cancer sup-
port the hypothesis that bone cancer pain is enhanced by
a state of spinal sensitization [6,7,13,16]. However little is
known about the functional changes in the synaptic pro-
cessing of nociceptive neuronal circuitry of the spinal
dorsal horn in animals bearing bone cancer.
The substantia gelatinosa (SG, lamina II) of the spinal
dorsal horn plays an important role in the transmission
and modulation of nociceptive information from the
periphery to the CNS [17-20], and is one of the key sites
for the generation of central sensitization in chronic neu-
ropathic pain states [15]. Fine myelinated Aδ and unmy-
elinated C afferent fibers terminate preferentially in the
SG. SG neurons exhibit glutamatergic excitatory postsyn-
aptic responses in response to stimulation of Aδ and C
afferent fibers [19,21-23] and naturalistic noxious stimu-
lation [24-26]. Following inflammation and peripheral
nerve injuries, the excitatory sensory pathways in the SG
are functionally reorganized: large fine myelinated Aβ
fibers establish aberrant synaptic contacts with SG neu-
rons [27-29]. The present study was designed to assess
whether excitatory sensory pathways and synaptic trans-
mission in the SG are changed in adult mice bearing bone
cancer using patch-clamp recordings from spinal cord
slices with an attached dorsal root. We compared excit-
atory synaptic responses evoked in SG neurons between
control mice and mice bearing cancer in the femur, and
show that the cancer-bearing mice exhibit unique plastic
changes in spinal excitatory synaptic transmission medi-
ated through Aδ and C afferent fibers.
Results
Spontaneous and movement-evoked pain-related 
behaviors and hypersensitivity to mechanical stimuli in 
mice with bone cancer
Mice had unilateral implantation of osteolytic murine
sarcoma cells into the femur [7,30]. After sarcoma
implantation, the animals exhibited spontaneous foot-
lifting behavior of the cancer-bearing limb. The number
of spontaneous flinches was significantly increased at day
7 after implantation, and the increment lasted for more
than 2 weeks (Figure 1A). Cancer-bearing mice also
exhibited impaired limb use during spontaneous ambula-
tion. The limb use score gradually decreased after sar-
coma implantation to reach a stable nadir at days 14 to 21
after sarcoma implantation (Figure 1B). A lower weight-
bearing score during standing was also observed in these
mice at days 7 to 21 after sarcoma implantation (Figure
1C). In contrast, sham-operated mice which received an
injection of culture medium without sarcoma cells in the
femur, had no spontaneous flinches and showed no
change in their limb use and weight-bearing scores (Fig-
ures 1A-C).
Next we examined the mechanical sensitivity of the
hind paw at days 14 and 21 after sarcoma implantation.
The paw withdrawal thresholds of the ipsilateral hind
paw (assessed with von Frey filaments) were significantly
lower than those on the contralateral side and also those
in control mice (Figure 1D). The values of the paw with-
drawal thresholds in sham-operated mice were similar to
those in control mice (data not shown). These results sug-
gest that the hindpaw of the cancer bearing limb has
developed hypersensitivity to mechanical stimuli applied
to the skin. Based on these initial findings we progressed
to search for electrophysiological evidence of changes in
spinal nociceptive processing in slice preparations of the
spinal cord obtained from mice 14 to 21 days after sar-
coma implantation. The excitatory synaptic responses in
the SG ipsilateral to the cancer-bearing side were com-
pared with those in control mice.
Increased amplitudes of spontaneous and miniature EPSCs 
in SG neurons of bone cancer-bearing mice
In the behavioral analysis, cancer-bearing mice exhibited
hyperalgesia in response to mechanical stimulation
applied to the hind paw. The hind paw afferent innerva-
tion synapses with second order neurons in the lumbar
spinal segments (mainly in L3-5) [31,32]. Therefore, we
first examined the passive membrane properties and the
synaptic inputs to SG neurons in the L3-5 segments. All
SG neurons examined had resting membrane potentials
more negative than -55 mV in control and cancer-bearing
mice. No differences were found in the resting membrane
potential (control, -65.3 ± 1.0 mV, n = 26; cancer, -65.7 ±
0.8 mV, n = 34; P = 0.98) and input membrane resistance
(control, 625.9 ± 62.8 MΩ, n = 26; cancer, 714.4 ± 34.5
MΩ, n = 34; P = 0.18) between the two groups.
SG neurons in control and cancer-bearing mice exhib-
ited spontaneous EPSCs (sEPSCs), recorded under volt-
age-clamp at a holding potential of -70 mV, (Figures 2A,
B). The frequency of sEPSCs was not significantly differ-
ent between the two groups (control, 10.4 ± 2.5 Hz, n =
18; cancer, 11.8 ± 3.2 Hz, n = 11; P = 0.36). The amplitudeYanagisawa et al. Molecular Pain 2010, 6:38
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of sEPSC, on the other hand, was significantly larger in
cancer-bearing than control mice (control, 17.0 ± 1.5 pA,
n = 18; cancer, 25.7 ± 3.7 pA, n = 11; P < 0.01) (Figure 2C).
In the presence of TTX, the amplitude of miniature EPSC
(mEPSCs) was still significantly larger in cancer-bearing
than control mice (control, 16.8 ± 1.6 pA, n = 18; cancer,
22.3 ± 2.6 pA, n = 11; P < 0.05) (Figures 2A, B, D). The
mEPSC frequency was not significantly different between
the two groups (control, 7.5 ± 1.9 Hz, n = 18; cancer, 11.5
± 3.1 Hz, n = 11, P = 0.12). These results suggest that
there is a facilitation of excitatory synaptic transmission
onto SG neurons at lumbar levels in mice bearing cancer
in the femur, but that there is no alteration in their pas-
sive membrane properties.
The femur, the bone bearing cancer in this study, is
innervated by the femoral nerve which has its central ter-
minations mainly in the upper lumbar levels of spinal
cord (L2-3) [12]. By contrast, the hind paw, which shows
mechanical hyperalgesia, is innervated by the sciatic
nerve which terminates mainly in lumbar segments L4-5
[31,32]. We further compared the amplitude and fre-
quency of mEPSCs in cancer-bearing mice among three
groups of SG neurons which were in different lumbar lev-
els: SG neurons in spinal cord slices at lumbar levels of
Figure 1 Spontaneous and movement evoked pain-related behaviors and mechanical hyperalgesia following sarcoma implantation in the 
femur. Time course of the number of spontaneous flinches of the cancer-bearing hind limb (A), unimpaired limb use score during spontaneous am-
bulation (B) and weight bearing score during standing (C) following sarcoma implantation (n = 6 for each test, closed circles). *Significantly different 
from the values obtained from sham-operated mice (n = 6 for each test, open squares), P < 0.05 (the Kruskal-Wallis test followed by the Scheffe test). 
Withdrawal thresholds to von Frey filament stimulation to the hind paw skin ipsilateral to cancer-bearing femur at 14 and 21 days after sarcoma im-
plantation (n = 14) (D). *Significantly different from the values for the stimulation applied to the contralateral paw of cancer-bearing mice (n = 14) and 
those obtained from control mice (n = 20), P < 0.05 (non-repeated measures ANOVA by post hoc test or Dunnett's test). Values represent means ± 
S.E.M.
1
3
0
2
Day after injection
71 4 2 1 0
Cancer
Sham
* * *
W
e
i
g
h
t
 
b
e
a
r
i
n
g
 
s
c
o
r
e
d
u
r
i
n
g
 
s
t
a
n
d
i
n
g
C Weight bearing
71 4 2 1 0
Day after injection
0
4
8
12
16
* * *
A Spontaneous flinches
Cancer
Sham
N
u
m
b
e
r
 
o
f
 
f
l
i
n
c
h
e
s
* *
*
Cancer
Sham
0
2
4
Day after injection
71 4 2 1 0
B Limb use
L
i
m
b
 
u
s
e
 
s
c
o
r
e
d
u
r
i
n
g
 
a
m
b
u
l
a
t
i
o
n
D
5
0
%
 
r
e
s
p
o
n
s
e
t
h
r
e
s
h
o
l
d
 
(
g
)
0
1
2
C
o
n
t
r
o
l
14 21
Day after injection
C
o
n
t
r
a
 
-
l
a
t
e
r
a
l
I
p
s
i
 
-
l
a
t
e
r
a
l
C
o
n
t
r
a
 
-
l
a
t
e
r
a
l
I
p
s
i
 
-
l
a
t
e
r
a
l
von Frey test
* * * *Yanagisawa et al. Molecular Pain 2010, 6:38
http://www.molecularpain.com/content/6/1/38
Page 4 of 13
L2-3, L4 or L5. However, there were no significant differ-
ences in the frequency (L2-3, 10.4 ± 3.1 Hz, n = 5; L4, 10.6
± 5.3 Hz, n = 6; L5, 10.7 ± 2.1 Hz, n = 12; P = 0.72) and
amplitude (L2-3, 16.8 ± 2.3 pA, n = 5; L4, 19.3 ± 3.2 pA, n
= 6; L5, 21.7 ± 2.6 pA, n = 12; P = 0.36) of mEPSCs among
the three groups in cancer-bearing mice (Figure 2E).
These results suggest that increased excitatory synaptic
responses in the SG are not restricted to the area of cen-
tral terminations of the afferent fibers innervating can-
cerous bones, and are detected throughout wide area of
Figure 2 Spontaneous and miniature EPSCs evoked in SG neurons at lumbar spinal levels in control and cancer-bearing mice. Representa-
tive traces of sEPSCs and mEPSCs in control (A) and cancer-bearing mice (B). Horizontal bars given above the traces show the duration of drug appli-
cation. Two lower records in A and B: consecutive traces of EPSCs in the absence (right) and presence (left) of TTX shown in an expanded scale in time. 
The frequency (left) and amplitude (right) of sEPSCs (C) and mEPSCs (D) in SG neurons at spinal levels of L3-5. The amplitudes of sEPSCs and mEPSCs 
were significantly larger in cancer-bearing than control mice, *P < 0.05 (unpaired t-test). The frequency and amplitude of mEPSCs at different lumber 
levels (L2-3, n = 5; L4, n = 6; L5, n = 12) in cancer-bearing mice (E). There were no significant differences in the frequency and amplitude of mEPSCs 
between the three groups. Values represent means ± S.E.M.
B 
10 s
50 ms
10 s
50 ms
20 pA
20 pA
TTX I μM
TTX I μM
A  Spontaneous EPSCs
Miniature EPSCs
0
10
20
30
A
m
p
l
i
t
u
d
e
 
(
p
A
)
Control  Cancer
**
0
5
10
15
20
Control  Cancer
F
r
e
q
u
e
n
c
y
 
(
H
z
)
0
10
20
30
A
m
p
l
i
t
u
d
e
 
(
p
A
)
Control  Cancer
*
0
L2-3 L4 L5
30
20
10
A
m
p
l
i
t
u
d
e
 
(
p
A
)
15
10
5
0
 
F
r
e
q
u
e
n
c
y
 
 
(
H
z
)
20
L2-3 L4 L5
F
r
e
q
u
e
n
c
y
 
(
H
z
)
0
5
10
15
20
Control  Cancer
C 
E
D 
Miniature EPSCsYanagisawa et al. Molecular Pain 2010, 6:38
http://www.molecularpain.com/content/6/1/38
Page 5 of 13
lumbar levels. To explore this further we examined syn-
aptic responses elicited in SG neurons at the lumbar lev-
els of L4-5 whose dermatomes include the hind paw.
Increased AMPA-induced currents and evoked EPSCs in 
bone cancer-bearing mice
In order to determine whether the increased amplitude of
mEPSCs in cancer-bearing mice was postsynaptic in ori-
g i n ,  w e  c o m p a r e d  A M P A - i n d u c e d  c u r r e n t s  e l i c i t e d  i n
postsynaptic SG neurons between the two groups. At a
holding potential of -70 mV, application of AMPA (10
μM) elicited an inward current in all SG neurons tested in
control and cancer-bearing mice. The peak amplitude of
the AMPA-induced current was significantly larger in
cancer-bearing than control mice (control, 127.2 ± 21.5
pA, n = 12; cancer, 260.0 ± 35.0 pA, n = 23; P < 0.01) (Fig-
ures 3A, B). The times to peak of the AMPA response in
control and cancer-bearing mice were 1.80 ± 0.27 min (n
= 12) and 1.53 ± 0.22 min (n = 23), respectively. There
was no significant difference between the groups (P  >
0.05, unpaired t-test).
Next we examined whether evoked synaptic responses
mediated by AMPA receptors were also enhanced in can-
cer-bearing mice. In the presence of a GABAA receptor
antagonist bicuculline (10 μM) and a glycine receptor
antagonist strychnine (2 μM), a monopolar stimulating
electrode was placed near the recorded SG neuron, and
EPSCs evoked by the focal stimulation were compared
between the two groups (at a holding potential of -70
mV). The focally evoked EPSCs were completely inhib-
ited by supplemental addition of CNQX (10 μM) (control,
n = 7; cancer, n = 15). The amplitude of focal AMPA
receptor-mediated EPSCs (focal AMPAR-EPSCs) was
significantly larger in cancer-bearing than control mice
(control, 101.1 ± 13.7 pA, n = 7; cancer, 226.8 ± 40.1 pA, n
= 15; P < 0.05) (Figures 3C, D). We further examined the
focally evoked EPSCs mediated by NMDA receptors
(focal NMDAR-EPSCs) in the two groups, in the pres-
ence of CNQX (10 μM), bicuculline (10 μM) and strych-
nine (2 μM) at a holding potential of +40 mV (to reveal
the NMDA mediated component). The focal NMDAR-
EPSCs had a long duration (~400 ms), and the responses
were completely suppressed by supplemental addition of
APV (50 μM; control, n = 2; cancer, n = 2). The amplitude
of focal NMDAR-EPSCs was also significantly increased
in cancer-bearing mice (control, 51.6 ± 18.4 pA, n = 7;
cancer, 116.4 ± 16.9 pA, n = 15; P < 0.05) (Figure 3E).
There was little correlation between the normalized focal
NMDAR- and AMPAR-EPSCs elicited in individual SG
neurons of cancer-bearing mice (r = 0.20) (Figure 3F).
This suggests that the AMPA and NMDA receptor-medi-
ated EPSCs in individual SG neurons are not concor-
dantly increased and also that the increased amplitudes
of the miniature and evoked responses of SG neurons in
cancer-bearing mice are unlikely to be due simply to an
increase in presynaptic glutamate release.
Plastic changes in spinal sensory pathways to SG neurons 
from afferent fibers in bone cancer-bearing mice
Previous studies have shown that spinal sensory pathways
to SG neurons from afferent fibers are drastically
changed in other neuropathic pain models such as
inflammation or peripheral nerve injuries [27-29]. To
evaluate whether the excitatory afferent synaptic inputs
to SG neurons were also changed in cancer-bearing mice,
EPSCs evoked by stimulation of the dorsal root attached
to the spinal cord slices were compared between the two
groups (Figure 4A). In control and cancer-bearing mice,
stimulation of the dorsal root evoked monosynaptic and/
or polysynaptic EPSCs in 48 out of 228 (21%) and 62 out
of 160 (39%) SG neurons, respectively. The dorsal root-
evoked EPSCs could be classified into two groups based
on the conduction velocities and stimulus intensities (Aδ
and C afferent fiber-evoked responses, see METHODS).
In control mice, monosynaptic Aδ and C fiber-evoked
EPSCs were detected in 13 and 12 SG neurons, respec-
tively, with an average conduction velocity of 3.50 ± 0.34
and 0.63 ± 0.04 m/s. Aδ and C fiber-evoked EPSCs in
cancer-bearing mice were detected in 14 and 10 SG neu-
rons, respectively, with an average conduction velocity of
3.00 ± 0.20 and 0.64 ± 0.04 m/s. The values of conduction
velocities for Aδ and C fiber-evoked EPSCs were consis-
tent with those obtained from SG neurons of rats [27-29].
There was no significant difference in the numbers of SG
neurons receiving the monosynaptic EPSCs from Aδ or C
fibers between the two groups (Table 1, χ2-test, P > 0.05)
(Table 1). The amplitude of monosynaptic Aδ fiber-
evoked EPSCs was not changed across groups (control,
199.0 ± 32.8 pA, n = 13; cancer, 199.6 ± 37.6 pA, n = 14; P
= 0.49) (Figures 4B, C). In contrast, the amplitude of
monosynaptic C fiber-evoked EPSCs was significantly
increased in cancer-bearing mice relative to that in con-
trol mice (control, 106.6 ± 31.7 pA, n = 12; cancer, 147.3
±13.8 pA, n = 10; P < 0.05) (Figures 4D, E). Furthermore,
the proportion of SG neurons receiving polysynaptic Aδ
or C fiber-evoked EPSCs was increased in cancer-bearing
mice (Table 1, χ2-test, P < 0.05). There were no changes in
the amplitude of polysynaptic Aδ fiber-evoked EPSCs
(control, 139.3 ± 23.7 pA, n = 26; cancer, 150.2 ± 14.0 pA,
n = 34, P = 0.33) nor in C fiber-evoked EPSCs (control,
78.1 ± 16.3 pA, n = 8; cancer, 99.3 ± 18.1 pA, n = 14; P =
0.22) between the two groups (Figure 5). These results
suggest that in addition to the enhanced monosynaptic
responses mediated through C fibers, the numbers of SG
neurons receiving excitatory polysynaptic inputs from Aδ
and C fibers are also increased in cancer-bearing mice.Yanagisawa et al. Molecular Pain 2010, 6:38
http://www.molecularpain.com/content/6/1/38
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Figure 3 AMPA-induced inward currents and focally evoked EPSCs in SG neurons of control and cancer-bearing mice. Representative traces 
of inward currents induced by bath-application of AMPA (10 μM) in control (left) and cancer-bearing mice (right) (A). The amplitude of AMPA-induced 
inward currents was significantly greater in cancer-bearing (n = 12) than control mice (n = 14), *P < 0.05 (unpaired t-test) (B). Representative averaged 
traces of EPSCs evoked by focal stimulation through an electrode positioned near the recorded neurons in control (left) and cancer-bearing (right) 
mice (C). The amplitude of the focal stimulation-evoked (AMPAR-) EPSCs was significantly larger in cancer-bearing mice (n = 7) than control mice (n 
= 15), *P < 0.05 (unpaired t-test) (D). The amplitude of the focal stimulation-evoked (NMDAR-) EPSCs was also significantly greater in cancer-bearing 
mice (n = 7) than control mice (n = 15), *P < 0.05 (unpaired t-test) (E). Relationship between the amplitudes of the focal AMPAR- and NMDAR-EPSCs 
evoked in single SG neurons of cancer-bearing mice (F). The amplitudes of the focal NMDAR- and AMPAR-EPSCs evoked in the same SG neurons of 
cancer-bearing mice were normalized to the average amplitudes of NMDAR- and AMPAR-EPSCs of control mice, respectively, and then the normalized 
amplitudes of NMDAR-EPSCs were plotted against those of AMPAR-EPSCs. The correlation coefficient of the linear regression for the normalized am-
plitudes of NMDAR- versus AMPAR-EPSCs was 0.20 (Linear regression; y = 0.17 × + 188.32, P > 0.05). Values represent means ± S.E.M.
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Figure 4 Monosynaptic afferent fiber-evoked EPSCs in SG neurons of control and cancer-bearing mice. Monosynaptic Aδ and C fiber-evoked 
EPSCs in response to the stimulation of dorsal root attached to the spinal cord slices (A). The monosynaptic nature was clarified based on their con-
stant latencies and absence of failures with repetitive stimulations (20 Hz and 2 Hz for Aδ and C fiber's responses, respectively; see Methods). Repre-
sentative averaged traces of monosynaptic Aδ fiber-evoked EPSCs in control (left) and cancer-bearing (right) mice (B). There was no significant 
difference in the amplitude of monosynaptic Aδ fiber-evoked EPSCs between control (n = 13) and cancer-bearing (n = 14) mice (right) (C). Represen-
tative averaged traces of C fiber-evoked EPSCs in control (left) and cancer-bearing (right) mice (D). The amplitude of monosynaptic C fiber-evoked 
EPSCs was significantly increased in cancer-bearing (n = 12) than control mice (n = 10), P < 0.05 (Mann-Whitney U-test) (E). Values represent means ± 
S.E.M.
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Discussion
The present study demonstrates that excitatory synaptic
transmission is functionally enhanced in the SG through-
out wide area of lumbar spinal levels in adult bone can-
cer-bearing mice. Furthermore we show that sensory
pathways to SG neurons from Aδ and C fibers are also
plastically altered. These widespread neural changes are
likely to contribute to the "referred" hyperalgesia that
develops in the hindpaw as the sarcoma grows in the
femur. The present results indicate that bone cancer
causes a unique spinal sensitization in noxious circuitry
that is different from that induced by other neuropathic
models such as peripheral nerve injuries and inflamma-
tion [15,27-29]. However these functional changes are
compatible with the previous studies of mice with femo-
ral bone cancer showing spinal neurochemical reorgani-
zations in multiple lumbar segments of the spinal cord
[7,13,16,33].
Figure 5 Polysynaptic afferent fiber-evoked EPSCs in SG neurons of control and cancer-bearing mice. Representative traces of polysynaptic 
Aδ fiber-evoked EPSCs elicited by the stimulation of the dorsal root at 20 Hz in control (left) and cancer-bearing mice (right) (A). There was no significant 
difference in the amplitude of polysynaptic Aδ fiber-evoked EPSCs between control (n = 26) and cancer-bearing (n = 34) mice (B). Representative trac-
es of polysynaptic C fiber-evoked EPSCs (indicated by arrowheads) elicited by the stimulation of the dorsal root at 2 Hz in control (left) and cancer-
bearing (right) mice (C). The neurons shown in C received polysynaptic C fiber-evoked EPSCs and Aδ fiber-evoked ones. There was no significant dif-
ference in the amplitude of polysynaptic C fiber-evoked EPSCs between control (n = 8) and (n = 14) cancer-bearing mice, P > 0.05 (unpaired t-test) 
(D). Values represent means ± S.E.M.
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Behavioral changes and plastic alterations in a large area of 
the spinal cord following cancer cell implantation in the 
femur
To study the pathophysiology of cancer pain, several ani-
mal models of bone cancer pain have been developed for
rodents [5-8]. We used the bone cancer model of
implanting NCTC2472 osteolytic sarcoma cells, because
this model is reproducible and most widely used
[7,9,11,13,34-36]. After sarcoma implantation into the
medullary space of the femur, the cancer-bearing mice
started showing pain-related behaviors at 7 to 21 days
(Figures 1A-C). These previous studies also reported ste-
reotyped, pain-related behaviors, which included flinch-
ing and limited limb use [9-12]. Interestingly, behavioral
changes suggesting hypersensitivity of the hind paw of
bone cancer models have been reported [9,12,13]. The
finding of lowered withdrawal threshold for mechanical
stimuli applied to the paw was confirmed in our study
(Figure 1D). These findings suggest that bone cancer may
induce a spinal sensitization over a wider area of the spi-
nal cord than just the segments in which the central ter-
minals of afferent fibers innervating the cancer-bearing
tissues are located. Specifically the spinal segments
receiving afferent fibers from the cancerous femur and
the hind paw, are relatively distinct (L1-L3 for the femur;
L3-5 for the paw) [12]. This notion is supported by the
observation that c-Fos expression is upregulated in L3-
L5, and GFAP labeling is increased in L2-L5 in animals
bearing cancer in the femur [7]. An increased astrogliosis
in the spinal cord segments of T10-S1 has been also
shown in mice bearing cancer in the femur [13]. The
present study is the first study demonstrating functional
enhancement of excitatory synaptic transmission in the
SG over a similarly wide area of lumbar levels (L2-5) in
mice bearing cancer in the femur (Figure 2).
Increased spinal excitatory synaptic responses in bone 
cancer model
To examine whether there was a change at the gateway of
the spinal sensory pathways in cancer-bearing mice, we
first compared the frequency and amplitude of sEPSCs
and mEPSCs in SG neurons. We found that the amplitude
of sEPSCs and mEPSCs were significantly increased,
whereas their frequencies were unchanged (Figure 2).
These results contrast with other neuropathic pain mod-
els, in which the amplitude and frequency of sEPSCs of
SG neurons are unaffected in peripheral nerve injury
models [27,29]. The increased amplitude and unchanged
frequency in cancer-bearing mice suggested a postsynap-
tic mechanism is operative to increase the synaptic
responses in SG neurons. To confirm this notion, we
measured the amplitude of inward currents elicited in SG
neurons by application of AMPA. This finding of an
increase in the amplitude of the AMPA-induced current
in cancer-bearing mice supports the postsynaptic mecha-
nism of enhancement (Figures 3A, B). An alternative
mechanism would posit that the increased EPSC ampli-
tude could result from an increased amount of presynap-
tic glutamate release. Therefore, we measured NMDAR
and AMPAR-EPSCs in the same neurons of cancer-bear-
ing mice, and showed that the amplitude of both EPSCs
was increased in cancer-bearing mice, but the increases
of NMDAR- and AMPAR-EPSCs in single SG neurons
were not correlated (Figure 3F), again supporting the
postsynaptic mechanism. Based on these results, we con-
clude that the increased amplitudes of excitatory synaptic
responses were mainly postsynaptic in origin, although
the possibility of presynaptic changes cannot be com-
pletely ruled out.
In the present study, we did not identify how postsyn-
aptic responses mediated by AMPA and NMDA recep-
tors were increased. In inflamed animals, the subunit
composition of AMPA receptors expressed in SG neu-
rons is reported to be changed [37]. Such changes in sub-
unit composition of AMPA receptors are known to alter
the kinetics of the synaptic currents [38]. We compared
the kinetics of the evoked EPSCs (decay time to 34% of
the response) between control and cancer-bearing mice.
The decay time constants of monosynaptic C fiber-
evoked EPSCs in control and model mice were 9.2 ± 1.9
ms (n = 7) and 8.0 ± 1.1 ms (n = 7), respectively. There is
no significant difference between the two groups (P  >
Table 1: Number of SG neurons receiving monosynaptic and polysynaptic inputs in control and bone cancer-bearing mice
Aδ fiber C fiber No input
Monosynaptic Control 13 (6%) 12 (5%) 203 (89%)
Cancer 14 (9%) 10 (6%) 136 (85%)
Polysynaptic Control 26 (11%) 8 (4%) 194 (85%)
Cancer 34 (21%) 14 (9%) 112 (70%)
The χ2-test revealed a significant difference in the number of cells receiving polysynaptic inputs from Aδ and C fibers between control and 
bone cancer-bearing mice (P < 0.05). The proportion of cells receiving monosynaptic inputs was not different across the groups.Yanagisawa et al. Molecular Pain 2010, 6:38
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0.05, unpaired t-test). Those for monosynaptic Aδ fiber-
evoked EPSCs also did not differ between the two groups
(control, 6.3 ± 1.0 ms, n = 9; model, 4.7 ± 0.9 ms, n = 8; P
> 0.05, unpaired t-test). These results suggest that the
increased responses in the bone cancer model mice may
be due to increased expression levels of the AMPA recep-
tors with similar kinetics. Previous studies have shown
that changes in spinal NMDA receptors are involved in
the development of bone cancer pain [36]. In bone cancer
models pain-related behaviors are accompanied by
increased expression of NR2B, an NMDA receptor sub-
unit. Interleukin, IL1β released from glial cells is reported
to facilitate bone cancer pain by enhancing phosphoryla-
tion of NMDA receptor NR-1 subunit [33]. In hippocam-
pal excitatory synapses, D-serine locally released from
astrocytes induces long-term potentiation mediated by
NMDAR [39]. Therefore, we hypothesize that chemical
mediators released from glial cells may control the ampli-
tude of synaptic responses in animals bearing bone can-
cer by changing expression levels of NMDA and AMPA
receptors and their phosphorylation. However, further
experiments will be needed to elucidate the functional
mechanisms of glutamate receptor enhancement in bone
cancer pain models.
Plastic changes in spinal sensory pathways from afferent 
fibers in bone cancer model
In this study, we recorded monosynaptic EPSCs in SG
neurons mediated through Aδ and C afferent fibers in
control and cancer-bearing mice. Most of the recorded
neurons did not receive mono- or polysynaptic inputs
from afferent fibers (Table 1). The percentage of neurons
receiving monosynaptic inputs was lower in comparison
with that in previous studies using rats [27,28]. This dif-
ference may be due to different experimental conditions,
such as the smaller size of the dorsal root attached to the
same thickness of transverse spinal cord slices or species
differences. Although the number of SG neurons receiv-
ing monosynaptic inputs from Aδ and C fibers was not
significantly different between control and cancer-bear-
ing mice, the amplitude of monosynaptic C fiber-evoked
EPSCs was significantly increased in cancer-bearing
mice, whereas that of monosynaptic Aδ fiber-evoked
EPSCs was unchanged (Figure 4). This represents a
unique functional alteration in the spinal synaptic trans-
mission compared with plastic changes in other chronic
pain models (see below). The magnitude of the increase
in amplitude of monosynaptic C fiber-evoked EPSCs is,
however, modest, compared with the changes in the
amplitude of AMPA-induced currents and focal EPSCs
(Figures 3B, D). This discrepancy suggests that in addi-
tion to the direct afferent inputs, other synaptic connec-
tions to SG neurons are also modified in cancer-bearing
mice. The changes could be detected by examining
polysynaptic responses: indeed the numbers of polysyn-
aptic inputs to SG neurons mediated through Aδ and C
fibers were also increased in cancer-bearing mice (Table
1). The enhanced polysynaptic inputs might be due to
increased excitability of spinal excitatory interneurons by
increased excitatory synaptic afferent responses as men-
tioned above. Consistent with our observation that excit-
atory synaptic inputs are increased, previous studies have
also shown that the excitability (firing rates) of dorsal
horn neurons in response to sensory stimulation are
increased, and their receptive field sizes are enlarged
[8,14,40]. Furthermore, in agreement with our finding
that the amplitude of monosynaptic inputs from C fibers
is increased, previous studies have demonstrated that fir-
ing rates of dorsal horn neurons in response to stimuli
that excite C fibers are increased in the bone cancer
model [8,41]. It has been reported that myelinated and
unmyelinated afferent fibers that innervate cancerous
femur are damaged [12,42]. As tumors grow, however,
tumor-associated inflammatory cells invade the neoplas-
tic tissue and release protons that generate local acidosis
[43]. This tumor-induced release of protons is likely to
activate acid sensing afferent fibers, in particular C fibers
expressing TRPV1 or ASIC channels that innervate the
f e m u r .  T h e  s e l e c t i v e  a c t i v a t i o n  o f  s u c h  a c i d - s e n s i n g  C
fibers may produce the augmented amplitude of the spi-
nal postsynaptic responses in an activity-dependent man-
ner. However, further studies will be needed to clarify
how monosynaptic C fiber-evoked response is specifi-
cally modified in bone cancer pain model. In other neuro-
pathic pain models (peripheral nerve injury and
inflammation models), mono or polysynaptic inputs
mediated through Aβ fibers are reported to be increased
in the SG [27-29]. In the present study, we could not
detect Aβ fiber-mediated EPSCs in SG neurons of both
normal and bone cancer-bearing mice. These differences
may account for the different mechanisms that generate
bone cancer pain and other neuropathic pain.
Conclusions
The present study demonstrated that bone cancer pain
causes an augmentation of excitatory synaptic transmis-
sion in the SG over a wide area of spinal lumbar segments
whose dermatomes include the hind paw, and a plastic
change in afferent synaptic inputs to SG neurons. This
spinal sensitization may be one of the underlying mecha-
nisms for the development of chronic bone cancer pain.
Methods
Animals
Experiments were conducted using adult male C3H/HeJ
mice (20 - 25 g, 4 - 6 weeks of age) purchased from Japan
SLC (Hamamatsu, Japan). The mice were housed in a
temperature-controlled room (21 ± 1°C) with a 12 h light/Yanagisawa et al. Molecular Pain 2010, 6:38
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dark cycle, and given free access to food and water. The
animal experiments were approved by the Sapporo Medi-
cal University Animal Care Committee and the commit-
tee of the ethics on Animal Experiment, Kyushu
University, and were conducted in accordance with the
Guidelines of the Japanese Physiological Society and the
Ethical Guidance and of the National Institutions of
Health, USA. All efforts were made to minimize animal
suffering and to reduce the number of animals that were
used.
Bone cancer pain model
Murine sarcoma cells (NCTC 2472; ATCC, Rockville,
MD, USA) were maintained in NCTC 135 media contain-
ing 10% horse serum (HyClone, Logan, UT, USA) and
passaged weekly according to the ATCC recommenda-
tion. Implantation of sarcoma cells was performed as pre-
viously described [16]. Briefly, mice were anesthetized
with isoflurane (3% in 100% oxygen), and a superficial
incision was made in the skin overlying the left patella.
The patellar ligament was then cut to expose the condyle
of the distal femur. A 0.5 mm depression was made using
a half-round burr in a pneumatic dental high-speed
handpiece to facilitate mechanical retention of the amal-
gam plug. Then, either 20 μl of α-minimum essential
medium (for sham-operated mice) or 20 μl of medium
containing 1×105 sarcoma cells was injected using a 0.25
ml syringe with a 29 gauge needle. To prevent leakage of
cells outside the bone, the injection site was closed with
dental-grade amalgam, followed by copious irrigation
with filtered water. The wound was then closed.
Behavioral analysis
Quantification of spontaneous flinches was used for
assessment of ongoing pain as described previously [44].
The number of spontaneous flinches was recorded dur-
ing a 2 min observation period. Flinches were defined as
holding of the hind paw aloft while not ambulatory. Limb
use during spontaneous ambulation was assigned scores
on a scale of 0 - 4: 0, complete lack of limb use; 1, relative
lack of use of the limb in locomotor activity; 2, limping
and guarding behavior; 3, substantial limping; 4, normal
use [11,44]. Weight-bearing during standing was scored
on a scale of 0 - 3: 0, no weight-bearing (the hind paw on
the injected side is always lifted and never touches the
floor); 1, touch weight-bearing (the hind paw on the
i n j e c t e d  s i d e  i s  l i f t e d  f r o m  t h e  f l o o r  b u t  o c c a s i o n a l l y
touches it); 2, partial weight-bearing (partial support of
body weight with the hind limb on the injected side); 3,
full weight-bearing (full support of 100% of body weight
with both hind limbs) [11,44]. In von Frey test, paw with-
drawal thresholds in response to probing with von Frey
filaments were determined in the manner described by
Chaplan et al [45]. Mice were kept in suspended cages
with a wire mesh floor, and von Frey filaments were
applied perpendicularly to the plantar surface of the ipsi-
lateral paw until it buckled slightly and was held for 3 sec-
onds. A positive response was indicated by a sharp
withdrawal of the paw. An initial probe equivalent to
0.008 g was applied and if the response was negative, the
stimulus was incrementally increased until a positive
response was obtained, then decreased until a negative
result was obtained. Mice were allowed to habituate for
30 min before the above all behavioral tests were per-
formed.
Preparation of spinal cord slices and electrophysiological 
recordings
The methods used to obtain mouse spinal cord slices with
an attached dorsal root were described elsewhere [46,47].
Briefly, the mouse was anesthetized with urethane (1.2 g/
kg, i.p.), and a lumbosacral laminectomy (Th11-S1) was
performed. The lumbar spinal cord (L1-L6) was removed
and placed in preoxygenated cold Krebs solution (1 -
3°C). The mouse was then immediately killed by exsan-
guination. After cutting all the ventral and dorsal roots
near the entry zone, except for the L4 or L5 dorsal root on
one side, the pia-arachnoid membrane was removed. The
spinal cord was mounted on a microslicer (DSK PRO7,
Dosaka, Kyoto, Japan) and then a 600-μm thick transverse
slice with the dorsal root was cut. T o compare mEPSCs
among three groups of SG neurons at different lumbar
levels (L2-3, L4 or L5) of spinal cord slices in cancer-bear-
ing mice, we made spinal cord slices with an attached
short length (1-2 mm) of rootlet of L2-3, L4 or L5. We
first identified the L5 root attached to isolated spinal
cord, since the width of L5 rootlet near the entry zone
was largest (~2 mm). We then identified the L4 and L2-3
whose rootlet widths were ~1.5 mm and ~1.2 mm,
respectively. All the roots were cut and removed except
for one short length of the rootlet of L2-3, L4 or L5. After
making the spinal cord slices, we identified the lumbar
level of slices with the rootlet. The slice was placed on a
nylon mesh in the recording chamber (a volume of 0.5
ml), and was completely submerged and perfused at a
rate of 12-15 ml/min with Krebs solution equilibrated
with 95% O2 and 5% CO2 at 36 ± 1°C. The Krebs solution
contained (in mM): 117 NaCl, 3.6 KCl, 2.5 CaCl2, 1.2
MgCl2, 1.2 NaH2PO4, 25 NaHCO3 and 11 glucose.
Blind whole-cell patch clamp recordings were made
from SG neurons with patch-pipette electrodes having a
resistance of 8 - 15 MΩ. Neurons in the SG were identi-
fied under a binocular microscope in which the SG could
be easily distinguished as a colorless band located in the
superficial dorsal horn as shown in adult rats [47,48]. The
composition of the patch-pipette solution was as follows
(in mM): 135 K-gluconate, 5 KCl, 0.5 CaCl2, 2 MgCl2, 5
EGTA, 5 HEPES, and 5 ATP (magnesium salt) (pH 7.2,Yanagisawa et al. Molecular Pain 2010, 6:38
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adjusted with KOH, 285 m osmol/l). Cs-based patch-
pipette solution composed of 110 Cs2SO4, 5 tetraeth-
ylammonium (TEA), 0.5 CaCl2, 2 MgCl2, 5 EGTA, 5
HEPES, and 5 ATP (magnesium salt) (pH 7.2, adjusted
with CsOH, 285 m osmol/l) was used for recording N-
methyl-D- a s p a r t a t e  ( N M D A )  r e c e p t o r  m e d i a t e d
responses at a holding potential of +40 mV. Signals were
acquired with an Axopatch 200B amplifier (Molecular
Devices, California, USA). Currents in the voltage-clamp
mode were low-pass filtered at 2-5 kHz and digitized at
333 kHz with an A/D converter (Digidata 1322, Molecu-
lar Device). The data were stored and analyzed using
Clampex 9.0 software (Molecular Device) and MiniAnal-
ysis software (version 6.0.7, Synaptosoft, Inc., Decatur,
USA). Focal EPSCs were evoked at a frequency of 0.2 Hz
by stimulation with a monopolar silver wire electrode
(diameter: 50 μm), insulated except for the tip, located
within 250 μm of the recorded neurons, as reported pre-
viously [49]. Root-evoked EPSCs were elicited by stimuli
given to the dorsal root at a frequency of 0.2 Hz (unless
otherwise mentioned) via a suction electrode. Aδ or C
fiber-evoked EPSCs were distinguished on the basis of
the conduction velocity of afferent fibers (Aδ, 2-13 m/s;
C, < 0.8 m/s) and stimulus threshold (Aδ, 10-60 μA; C,
160-530 μA), as described previously [28]. The Aδ and C
responses were considered as monosynaptic in origin
when the latency remained constant and there was no
failure during stimulation at 20 Hz for the Aδ fiber-
evoked EPSCs, and at 2 Hz for the C fiber-evoked EPSCs
[28]. The threshold for polysynaptic inputs was some-
times higher than that for monosynaptic inputs. How-
ever, the threshold for polysynaptic Aδ fiber-evoked
inputs were always lower than those for monosynaptic C
fiber-evoked EPSCs. For the Aδ fiber-evoked EPSCs,
therefore, we differentiated between mono- or polysyn-
aptic nature with the stimulus intensity which is 1.5 times
higher than the threshold and yet is still much lower than
that for C fibers. To know whether polysynaptic C fiber
inputs are evoked in recorded neurons, we used a supra-
maximal amplitude of stimulus current (10 mA) for all of
the recorded cells.
Statistical analysis
All numerical data are expressed as mean ± SEM. Statisti-
cal significance was determined at the P < 0.05 level using
unpaired t-test or Mann-Whitney U-test at comparison
between 2 groups, and using non-repeated measures
ANOVA by post hoc test or Dunnett's test at comparison
between 3 groups.
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